Respiri Limited (RSH.AX)
AUD 0.07
(-4.0%)
AUD 0.07
(-4.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -7.04 Million AUD | -22.64% |
| 2023 | -5.74 Million AUD | 11.22% |
| 2022 | -7.03 Million AUD | 41.5% |
| 2021 | -11.94 Million AUD | -27.82% |
| 2020 | -9.4 Million AUD | 0.52% |
| 2019 | -9.49 Million AUD | -139.72% |
| 2018 | -3.94 Million AUD | -29.36% |
| 2017 | -3.05 Million AUD | 19.05% |
| 2016 | -3.78 Million AUD | 28.33% |
| 2015 | -5.24 Million AUD | 51.9% |
| 2014 | -10.97 Million AUD | -110.12% |
| 2013 | -5.44 Million AUD | -8.37% |
| 2012 | -5.12 Million AUD | 26.74% |
| 2011 | -6.58 Million AUD | -12.12% |
| 2010 | -5.86 Million AUD | 11.55% |
| 2009 | -6.62 Million AUD | 27.64% |
| 2008 | -12.33 Million AUD | -79.8% |
| 2007 | -3.55 Million AUD | -2459.49% |
| 2006 | -1.01 Million AUD | 71.13% |
| 2005 | -742.18 Thousand AUD | 17.22% |
| 2004 | -833.9 Thousand AUD | 78.91% |
| 2003 | -4.16 Million AUD | 65.76% |
| 2002 | -11.54 Million AUD | -33.29% |
| 2001 | -8.66 Million AUD | -48.18% |
| 2000 | -5.84 Million AUD | -225.41% |
| 1999 | -1.79 Million AUD | -151.51% |
| 1998 | -714.42 Thousand AUD | -141.01% |
| 1997 | 1.74 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -3.61 Million AUD | 0.0% |
| 2024 FY | - AUD | -25.73% |
| 2024 Q4 | -4.01 Million AUD | 0.0% |
| 2023 Q2 | -3.12 Million AUD | 0.0% |
| 2023 Q4 | -3.14 Million AUD | 0.0% |
| 2023 FY | - AUD | 11.22% |
| 2022 Q2 | -3.52 Million AUD | 0.0% |
| 2022 FY | - AUD | 41.5% |
| 2022 Q4 | -3.54 Million AUD | 0.0% |
| 2021 Q4 | -4.69 Million AUD | 0.0% |
| 2021 Q2 | -7.43 Million AUD | 0.0% |
| 2021 FY | - AUD | -27.82% |
| 2020 FY | - AUD | 0.52% |
| 2020 Q2 | -3.57 Million AUD | 0.0% |
| 2020 Q4 | -5.88 Million AUD | 0.0% |
| 2019 FY | - AUD | -139.72% |
| 2019 Q4 | -4.34 Million AUD | 0.0% |
| 2019 Q2 | -3.1 Million AUD | 0.0% |
| 2018 FY | - AUD | -29.36% |
| 2018 Q2 | -672.11 Thousand AUD | 0.0% |
| 2018 Q4 | -2.42 Million AUD | 0.0% |
| 2017 Q2 | -1.72 Million AUD | 0.0% |
| 2017 Q4 | -517.11 Thousand AUD | 0.0% |
| 2017 FY | - AUD | 19.05% |
| 2016 Q4 | -1.28 Million AUD | 0.0% |
| 2016 Q2 | -2.49 Million AUD | 0.0% |
| 2016 FY | - AUD | 28.33% |
| 2015 Q4 | -2.29 Million AUD | 0.0% |
| 2015 FY | - AUD | 51.9% |
| 2015 Q2 | -2.98 Million AUD | 0.0% |
| 2014 Q2 | -7.08 Million AUD | 0.0% |
| 2014 FY | - AUD | -110.12% |
| 2014 Q4 | -3.89 Million AUD | 0.0% |
| 2013 Q2 | -2.88 Million AUD | -124.99% |
| 2013 Q1 | -1.28 Million AUD | 0.0% |
| 2013 FY | - AUD | -8.37% |
| 2013 Q4 | -2.55 Million AUD | -90.31% |
| 2013 Q3 | -1.34 Million AUD | 53.38% |
| 2012 Q4 | - AUD | 100.0% |
| 2012 FY | - AUD | 26.74% |
| 2012 Q2 | -1.28 Million AUD | 20.56% |
| 2012 Q3 | -1.28 Million AUD | 0.0% |
| 2012 Q1 | -1.61 Million AUD | 0.0% |
| 2011 Q2 | -1.61 Million AUD | -13.53% |
| 2011 Q1 | -1.42 Million AUD | 0.0% |
| 2011 FY | - AUD | -12.12% |
| 2011 Q4 | - AUD | 100.0% |
| 2011 Q3 | -1.61 Million AUD | 0.0% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 Q3 | -1.42 Million AUD | 0.0% |
| 2010 Q1 | -1.6 Million AUD | 0.0% |
| 2010 Q2 | -1.42 Million AUD | 11.64% |
| 2010 FY | - AUD | 11.55% |
| 2009 Q3 | -1.6 Million AUD | 0.0% |
| 2009 Q2 | -1.6 Million AUD | 44.05% |
| 2009 Q4 | - AUD | 100.0% |
| 2009 FY | - AUD | 27.64% |
| 2009 Q1 | -2.87 Million AUD | 0.0% |
| 2008 Q2 | -2.87 Million AUD | -125.55% |
| 2008 Q4 | - AUD | 100.0% |
| 2008 FY | - AUD | -79.8% |
| 2008 Q1 | -1.27 Million AUD | 0.0% |
| 2008 Q3 | -2.87 Million AUD | 0.0% |
| 2007 Q1 | -254.86 Thousand AUD | 0.0% |
| 2007 FY | - AUD | -2459.49% |
| 2007 Q4 | - AUD | 100.0% |
| 2007 Q3 | -1.27 Million AUD | 0.0% |
| 2007 Q2 | -1.27 Million AUD | -400.15% |
| 2006 Q3 | -254.86 Thousand AUD | 0.0% |
| 2006 Q2 | -254.86 Thousand AUD | 29.61% |
| 2006 FY | - AUD | 71.13% |
| 2006 Q4 | - AUD | 100.0% |
| 2006 Q1 | -362.09 Thousand AUD | 0.0% |
| 2005 FY | - AUD | 17.22% |
| 2005 Q3 | -362.09 Thousand AUD | 0.0% |
| 2005 Q2 | -362.09 Thousand AUD | -221.23% |
| 2005 Q1 | -112.72 Thousand AUD | 0.0% |
| 2005 Q4 | - AUD | 100.0% |
| 2004 Q1 | -2.11 Million AUD | 0.0% |
| 2004 Q2 | -112.72 Thousand AUD | 94.67% |
| 2004 Q3 | -112.72 Thousand AUD | 0.0% |
| 2004 Q4 | - AUD | 100.0% |
| 2004 FY | - AUD | 78.91% |
| 2003 Q4 | - AUD | 100.0% |
| 2003 Q1 | -5.85 Million AUD | 0.0% |
| 2003 Q2 | -2.11 Million AUD | 63.88% |
| 2003 Q3 | -2.11 Million AUD | 0.0% |
| 2003 FY | - AUD | 65.76% |
| 2002 Q3 | -5.85 Million AUD | 0.0% |
| 2002 Q1 | -4.28 Million AUD | 0.0% |
| 2002 Q4 | - AUD | 100.0% |
| 2002 Q2 | -5.85 Million AUD | -36.69% |
| 2002 FY | - AUD | -33.29% |
| 2001 Q1 | -2.99 Million AUD | 0.0% |
| 2001 Q4 | - AUD | 100.0% |
| 2001 Q3 | -4.28 Million AUD | 0.0% |
| 2001 Q2 | -4.28 Million AUD | -43.19% |
| 2001 FY | - AUD | -48.18% |
| 2000 Q3 | -2.99 Million AUD | 0.0% |
| 2000 Q1 | -449.2 Thousand AUD | 0.0% |
| 2000 FY | - AUD | -225.41% |
| 2000 Q4 | -2.99 Million AUD | 0.0% |
| 2000 Q2 | -2.99 Million AUD | -565.68% |
| 1999 FY | - AUD | -151.51% |
| 1999 Q3 | -449.2 Thousand AUD | 0.0% |
| 1999 Q4 | -449.2 Thousand AUD | 0.0% |
| 1999 Q2 | -449.2 Thousand AUD | -151.51% |
| 1999 Q1 | -178.6 Thousand AUD | 0.0% |
| 1998 Q4 | -178.6 Thousand AUD | 0.0% |
| 1998 Q3 | -178.6 Thousand AUD | 0.0% |
| 1998 FY | - AUD | -141.01% |
| 1998 Q1 | 144.37 Thousand AUD | 0.0% |
| 1998 Q2 | -178.6 Thousand AUD | -223.71% |
| 1997 FY | - AUD | 0.0% |
| 1997 Q4 | 144.37 Thousand AUD | 0.0% |
| 1997 Q2 | 144.37 Thousand AUD | 0.0% |
| 1997 Q3 | 144.37 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 80.453% |
| Adherium Limited | -11.56 Million AUD | 39.038% |
| Aroa Biosurgery Limited | -7.36 Million AUD | 4.214% |
| Atomo Diagnostics Limited | -5.42 Million AUD | -29.988% |
| Anteris Technologies Ltd | -66.9 Million AUD | 89.463% |
| Control Bionics Limited | -5.15 Million AUD | -36.674% |
| CardieX Limited | -6.71 Million AUD | -5.037% |
| Compumedics Limited | 2.78 Million AUD | 352.776% |
| Cochlear Limited | 579.5 Million AUD | 101.217% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -101.899% |
| Cyclopharm Limited | -3.03 Million AUD | -132.295% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -237.121% |
| Nova Eye Medical Limited | -5.97 Million AUD | -17.911% |
| HeraMED Limited | -3.97 Million AUD | -77.487% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 67.765% |
| ImpediMed Limited | -22.05 Million AUD | 68.029% |
| InhaleRx Limited | -1.41 Million AUD | -398.67% |
| LBT Innovations Limited | -4.04 Million AUD | -74.115% |
| Micro-X Limited | -14.35 Million AUD | 50.875% |
| Neurotech International Limited | -8.24 Million AUD | 14.485% |
| OncoSil Medical Limited | -11.97 Million AUD | 41.134% |
| PolyNovo Limited | 5.17 Million AUD | 236.362% |
| SomnoMed Limited | -2.32 Million AUD | -202.751% |
| Universal Biosensors, Inc. | -9.09 Million AUD | 22.447% |
| Uscom Limited | -1.5 Million AUD | -367.095% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | -43.367% |